Chronic Inflammatory Diseases, Anti-Inflammatory Agents and Their Delivery Nanosystems
Inflammatory diseases, whether caused by excessive stress on certain tissues/parts of the body or arising from infections accompanying autoimmune or secondary diseases, have become a problem, especially in the Western world today. Whether these are inflammations of visceral organs, joints, bones, or...
Main Authors: | Daniela Placha, Josef Jampilek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/1/64 |
Similar Items
-
Modulation of Macrophages Using Nanoformulations with Curcumin to Treat Inflammatory Diseases: A Concise Review
by: Huxiao Sun, et al.
Published: (2022-10-01) -
Recent Advances in Nanoformulations for Quercetin Delivery
by: Ekaterina-Michaela Tomou, et al.
Published: (2023-06-01) -
Controlled Delivery of an Anti-Inflammatory Toxin to Macrophages by Mutagenesis and Nanoparticle Modification
by: Ayaka Harada, et al.
Published: (2022-06-01) -
Reverse Transcriptase Inhibitors Nanosystems Designed for Drug Stability and Controlled Delivery
by: Fedora Grande, et al.
Published: (2019-04-01) -
Mannose-Decorated Solid-Lipid Nanoparticles for Alveolar Macrophage Targeted Delivery of Rifampicin
by: Hriday Bera, et al.
Published: (2024-03-01)